New Cervical Cancer Treatment Replaces Chemo for Early-Stage Disease
For decades, chemotherapy paired with radiation has been the backbone of cervical cancer treatment, even for patients with early-stage disease who might...
Category Dementia
New Oral Drug for Primary Progressive MS Approved — Years in the Making
Despite the hopeful framing of this headline, the full picture requires an honest clarification: as of March 2026, no oral drug has yet received FDA...
New Psoriasis Drug Achieves Total Skin Clearance in Over Half of Patients
A new wave of psoriasis treatments is pushing the boundaries of what dermatologists once thought possible, with several drugs now achieving total skin...
The Oral Thrombectomy Drug Showing Promise for Stroke
A class of oral drugs designed to dissolve blood clots — sometimes referred to as oral thrombectomy agents or next-generation thrombolytics — has been...
New Gene Therapy for Hemophilia B Eliminates Need for Injections
A single intravenous infusion is now capable of freeing people with Hemophilia B from a lifetime of routine clotting factor injections.
The Drug That Controls Parkinson’s Tremors Without Affecting Thinking
Levodopa, often sold under the brand name Sinemet when combined with carbidopa, remains the gold standard drug for controlling Parkinson's tremors while...
This Topical Drug Is Replacing Oral Antibiotics for Rosacea
A topical minocycline foam called Zilxi is rapidly changing how dermatologists treat rosacea, offering the anti-inflammatory benefits of oral antibiotics...
New Oral Testosterone Gets FDA Approval — Why This Is Different
For decades, men with clinically low testosterone faced a narrow set of options: needles, gels that could rub off on family members, or older oral pills...
Rybelsus Oral Semaglutide: The GLP-1 Pill Challenging Injections
Rybelsus is the first and only oral semaglutide tablet approved for type 2 diabetes management, offering the same GLP-1 receptor agonist mechanism found...
The Hormone Therapy Reducing Breast Cancer Risk by 50 Percent
Tamoxifen, a selective estrogen receptor modulator first approved by the FDA for breast cancer prevention in 1999, reduced the risk of invasive breast...